Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.41)
# 2,333
Out of 5,182 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $49 → $47 | $40.89 | +15.16% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $115.06 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $173.14 | +344.73% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $37.59 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $75.34 | -9.74% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $11.71 | +463.62% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $120.93 | +138.15% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $496.11 | -47.59% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $320.00 | -34.06% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $4.35 | +1,141.38% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $193.03 | -78.76% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $279.25 | +19.96% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $277.00 | +20.94% | 1 | Sep 20, 2018 |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $49 → $47
Current: $40.89
Upside: +15.16%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $115.06
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $173.14
Upside: +344.73%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $37.59
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $75.34
Upside: -9.74%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $11.71
Upside: +463.62%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $120.93
Upside: +138.15%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $496.11
Upside: -47.59%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $320.00
Upside: -34.06%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $4.35
Upside: +1,141.38%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $193.03
Upside: -78.76%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $279.25
Upside: +19.96%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $277.00
Upside: +20.94%